查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1988936

2026年全球體外診斷（IVD）品管市場報告

In Vitro Diagnostics (IVD) Quality Control Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體外診斷（IVD）品管市場顯著擴張。預計該市場將從2025年的14.8億美元成長到2026年的16.1億美元，複合年成長率（CAGR）為8.5%。過去幾年成長要素包括感染疾病負擔日益加重、IVD設備的廣泛應用、監管機構對診斷準確性的日益重視、臨床實驗室網路的擴張以及人們對實驗室質量標準的日益關注。

體外診斷（IVD）品管市場預計在未來幾年將保持強勁成長，到2030年將達到22.4億美元，複合年成長率（CAGR）為8.6%。預測期內的成長預計將受到以下因素的推動：對分子診斷更高精度的需求不斷成長、醫療保健數位化進程的推進、自動化檢測系統的擴展、醫療基礎設施投資的增加以及監管合規要求的日益嚴格。預測期內的主要趨勢包括：更加重視診斷的準確性和可靠性、日益關注品質合規性和標準化、外部品質評估項目的擴展、多重和分子診斷測試檢驗的加強以及自動化品質監控系統的廣泛應用。

感染疾病的日益流行預計將推動體外診斷（IVD）品管市場的成長。感染疾病是由細菌、病毒、真菌和寄生蟲等致病微生物引起的疾病，可透過人與人之間的直接或間接傳播。由於抗生素抗藥性的增加等因素，感染疾病的盛行率正在上升。這使得常見感染疾病的治療和控制變得更加困難，從而促進了感染的傳播。 IVD品管在確保診斷測試結果的準確性、可靠性和一致性方面發揮著至關重要的作用，有助於早期發現感染疾病病原體，並支持有效的臨床決策和患者管理。例如，根據總部位於瑞士的國際公共衛生組織－世界衛生組織（WHO）的數據，截至2024年10月，2023年全球約有820萬人新確診結核病，高於2022年的約750萬人，使結核病成為全球最致命的感染疾病。因此，感染疾病的蔓延推動了體外診斷（IVD）品管市場的成長。

體外診斷 (IVD)品管市場的主要企業正致力於整合先進技術，例如嵌入式條碼掃描系統，以提高效率、簡化診斷工作流程並減少處理錯誤。嵌入式條碼掃描系統是緊湊型固定設備和智慧視覺模組，可自動讀取條碼並即時擷取資料。這有助於在整個診斷過程中實現準確的檢體識別、自動資料輸入和更高的可追溯性。例如，2023 年 11 月，總部位於荷蘭的數位科技公司 Newland EMEA 在 MEDICA展覽會上發表了一系列全新的 IVD 專用條碼掃描產品。該產品系列包括高速掃描器 FM510 和 FM530、功能全面的 FM550 以及智慧攝影機 FM600，所有這些產品都旨在推動 IVD檢查室的自動化，提高診斷速度和準確性。此次新產品發布表明，診斷品管領域對自動化和資料完整性的關注度日益提高。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球體外診斷（IVD）品管市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 人們越來越重視診斷的準確性和可靠性。
    • 人們越來越關注品質合規性和標準化
    • 擴大外部品質評估方案的採用範圍
    • 擴大多重和分子診斷測試的驗證範圍
    • 擴大自動化品質監控系統的應用

第5章 終端用戶產業市場分析

  • 醫院
  • 臨床檢查室
  • 診斷中心
  • 研究和學術機構
  • 標準檢驗組織

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球體外診斷（IVD）品管市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球體外診斷（IVD）品管市場規模、對比及成長率分析
  • 全球體外診斷（IVD）品管市場表現：規模與成長，2020-2025年
  • 全球體外診斷（IVD）品管市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依產品類型
  • 品管產品、資料管理解決方案、品質保證服務
  • 按製造商類型
  • 體外診斷設備製造商，第三方品管製造商
  • 透過使用
  • 臨床化學、血液學、免疫檢測、分子診斷、微生物學、凝血及止血及其他應用。
  • 最終用戶
  • 醫院、臨床檢查室、研究和學術機構以及其他最終用戶
  • 按類型細分：品管產品
  • 標準材料、品管工具包和能力測試樣品。
  • 按類型細分：資料管理解決方案
  • 品管軟體、數據分析工具和基於雲端的解決方案。
  • 按類型細分：品質保證服務
  • 諮詢服務、培訓和教育服務、審計和合規服務

第10章 區域與國別分析

  • 全球體外診斷（IVD）品管市場：按地區分類，實際數據和預測數據，2020-2025年、2025-2030年、2035年
  • 全球體外診斷（IVD）品管市場：按國家分類，實際結果和預測，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 體外診斷（IVD）品管市場：競爭格局與市場佔有率，2024年
  • 體外診斷（IVD）品管市場：公司評估矩陣
  • 體外診斷（IVD）品管市場：公司簡介
    • Bio-Rad Laboratories Inc.
    • Thermo Fisher Scientific Inc.
    • LGC Limited.
    • Abbott Laboratories
    • Roche Diagnostics AG

第37章 其他大型企業和創新企業

  • Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：具有高市場潛力的國家、細分市場與策略

  • 2030年體外診斷（IVD）品管市場：提供新機會的國家
  • 2030年體外診斷（IVD）品管市場：充滿新機會的細分市場
  • 2030年體外診斷（IVD）品管市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: SE3MIVDI01_G26Q1

In-vitro diagnostics (IVD) quality control encompasses a set of processes designed to ensure the accuracy, performance, and environmental conditions impacting in vitro diagnostic tests, including in vitro nucleic acid testing processes for pathogen detection and healthcare-associated infections (HAIs) like pneumonia and urinary tract infections.

The primary products in in-vitro diagnostics quality control include quality control products, data management solutions, and quality assurance services. Quality control products comprise serum/plasma-based control products, whole blood-based control products, urine-based control products, and other control products manufactured by IVD instrument manufacturers. These products aim to cure, mitigate, or treat conditions through in-vitro diagnostics quality control. Manufacturers can be categorized as IVD instrument manufacturers and third-party quality control manufacturers. These products find applications in various diagnostic areas, such as clinical chemistry, hematology, immunoassay, molecular diagnostics, microbiology, coagulation, or hemostasis, among others. The implementation of in-vitro diagnostics quality control occurs in various settings, including hospitals, clinical laboratories, research and academic institutes, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the in vitro diagnostics quality control market by increasing the costs of control materials, software platforms, and quality assurance kits that depend on cross border manufacturing and sourcing. These effects are particularly evident in molecular diagnostics, immunoassay, and clinical chemistry segments, as well as in regions where IVD imports form a major share of supply such as Asia Pacific and Europe. However, tariffs are also encouraging localization of IVD quality control production and regional manufacturing investments, supporting domestic capability building. Overall, tariffs are reshaping procurement strategies while pushing stakeholders toward supply diversification and cost optimization initiatives.

The in vitro diagnostics (ivd) quality control market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostics (ivd) quality control market statistics, including in vitro diagnostics (ivd) quality control industry global market size, regional shares, competitors with a in vitro diagnostics (ivd) quality control market share, detailed in vitro diagnostics (ivd) quality control market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro diagnostics (ivd) quality control industry. This in vitro diagnostics (ivd) quality control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vitro diagnostics (ivd) quality control market size has grown strongly in recent years. It will grow from $1.48 billion in 2025 to $1.61 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to growing burden of infectious diseases, rising adoption of in vitro diagnostic devices, regulatory focus on diagnostic accuracy, expansion of clinical laboratory networks, increasing awareness of testing quality standards.

The in vitro diagnostics (ivd) quality control market size is expected to see strong growth in the next few years. It will grow to $2.24 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for molecular diagnostics precision, increasing healthcare digitalization, growing adoption of automated lab systems, expanding healthcare infrastructure investments, stricter regulatory compliance requirements. Major trends in the forecast period include increasing emphasis on diagnostic accuracy and reliability, rising focus on quality compliance and standardization, growing adoption of external quality assessment programs, expansion of multiplex and molecular diagnostic testing validation, increasing use of automated quality monitoring systems.

The rising prevalence of infectious diseases is expected to propel the growth of the in vitro diagnostics (IVD) quality control market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals. The prevalence of infectious diseases is increasing due to factors such as growing antimicrobial resistance, which makes common infections more difficult to treat and control, thereby facilitating wider transmission. IVD quality control plays a critical role in ensuring the accuracy, reliability, and consistency of diagnostic test results, enabling timely detection of infectious pathogens and supporting effective clinical decision-making and patient management. For instance, in October 2024, according to the World Health Organization (WHO), a Switzerland-based international public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, making tuberculosis the leading infectious disease killer globally. Therefore, the rising prevalence of infectious diseases is driving the growth of the in vitro diagnostics (IVD) quality control market.

Major companies operating in the in vitro diagnostics (IVD) quality control market are focusing on integrating advanced technologies such as embedded barcode-scanning systems to improve efficiency, streamline diagnostic workflows, and reduce processing errors. Embedded barcode-scanning systems are compact fixed-mount devices and smart vision modules that automatically read barcodes and capture data in real time, enabling accurate specimen identification, automated data entry, and enhanced traceability throughout the diagnostic process. For instance, in November 2023, Newland EMEA, a Netherlands-based digital technology company, launched a new line of IVD-focused barcode-scanning products at the MEDICA trade fair. The portfolio includes high-speed scanners such as the FM510 and FM530, the versatile FM550, and the smart FM600 camera, all designed to enhance automation, improve diagnostic speed, and increase accuracy in IVD laboratories. This launch highlights the growing emphasis on automation and data integrity in diagnostic quality control.

In May 2024, Bruker, a US-based analytical instrumentation company, acquired ELITechGroup for €870 ($948) million. This acquisition aims to strengthen Bruker's position in the molecular diagnostics market by integrating ELITech's innovative sample-to-answer platforms along with its diverse portfolio of assays for infectious diseases. ELITech, also a US-based in-vitro diagnostics company, develops, manufactures, and markets a wide range of advanced diagnostic products and solutions, which include instruments, reagents, and software.

Major companies operating in the in vitro diagnostics (ivd) quality control market report are Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., LGC Limited., Abbott Laboratories, Roche Diagnostics AG, Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc., Qiagen NV, Becton Dickinson and Company, Luminex Corporation, BioMerieux SA, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ZeptoMetrix Corporation, Maine Molecular Quality Controls Inc.

North America was the largest region in the in vitro diagnostics (IVD) quality control market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics (ivd) quality control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostics (ivd) quality control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in-vitro diagnostics (IVD) quality control market consists of revenues earned by entities that evaluate and validate the reliability of in-vitro diagnostics testing systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics (IVD) Quality Control Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in vitro diagnostics (ivd) quality control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics (ivd) quality control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro diagnostics (ivd) quality control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product type: Quality Control Products; Data Management Solutions; Quality Assurance Services
  • 2) By Manufacturer Type: IVD Instrument Manufacturers; Third Party Quality Control Manufacturers
  • 3) By Application: Clinical Chemistry; Hematology; Immunoassay; Molecular Diagnostics; Microbiology; Coagulation Or Hemostasis; Other Applications
  • 4) By End-Users: Hospitals; Clinical Laboratories; Research And Academic Institutes; Other End Users
  • Subsegments:
  • 1) By Quality Control Products: Control Materials; Quality Control Kits; Proficiency Testing Samples
  • 2) By Data Management Solutions: Software For Quality Control Management; Data Analysis Tools; Cloud-Based Solutions
  • 3) By Quality Assurance Services: Consulting Services; Training And Education Services; Audit And Compliance Services
  • Companies Mentioned: Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; LGC Limited.; Abbott Laboratories; Roche Diagnostics AG; Siemens AG; Ortho Clinical Diagnostics Inc.; Helena Laboratories Corporation; Quidel Corporation; Microbiologics Inc.; Sun Diagnostics LLC; Fortress Diagnostics Ltd.; Seegene Inc.; Bio-Techne Corp.; Randox Laboratories; Danaher Corporation; Sysmex Corporation; Beckman Coulter Inc.; Grifols India Healthcare Private Limited.; Hologic Inc.; Qiagen NV; Becton Dickinson and Company; Luminex Corporation; BioMerieux SA; Meridian Bioscience Inc.; Sekisui Diagnostics LLC; ZeptoMetrix Corporation; Maine Molecular Quality Controls Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. In Vitro Diagnostics (IVD) Quality Control Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global In Vitro Diagnostics (IVD) Quality Control Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. In Vitro Diagnostics (IVD) Quality Control Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global In Vitro Diagnostics (IVD) Quality Control Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Emphasis On Diagnostic Accuracy And Reliability
    • 4.2.2 Rising Focus On Quality Compliance And Standardization
    • 4.2.3 Growing Adoption Of External Quality Assessment Programs
    • 4.2.4 Expansion Of Multiplex And Molecular Diagnostic Testing Validation
    • 4.2.5 Increasing Use Of Automated Quality Monitoring Systems

5. In Vitro Diagnostics (IVD) Quality Control Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinical Laboratories
  • 5.3 Diagnostic Centers
  • 5.4 Research And Academic Institutes
  • 5.5 Reference Laboratories

6. In Vitro Diagnostics (IVD) Quality Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global In Vitro Diagnostics (IVD) Quality Control Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global In Vitro Diagnostics (IVD) Quality Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global In Vitro Diagnostics (IVD) Quality Control Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global In Vitro Diagnostics (IVD) Quality Control Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global In Vitro Diagnostics (IVD) Quality Control Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global In Vitro Diagnostics (IVD) Quality Control Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. In Vitro Diagnostics (IVD) Quality Control Market Segmentation

  • 9.1. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Quality Control Products, Data Management Solutions, Quality Assurance Services
  • 9.2. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • IVD Instrument Manufacturers, Third Party Quality Control Manufacturers
  • 9.3. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis, Other Applications
  • 9.4. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinical Laboratories, Research And Academic Institutes, Other End Users
  • 9.5. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Quality Control Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Control Materials, Quality Control Kits, Proficiency Testing Samples
  • 9.6. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Data Management Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software For Quality Control Management, Data Analysis Tools, Cloud-Based Solutions
  • 9.7. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Quality Assurance Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting Services, Training And Education Services, Audit And Compliance Services

10. In Vitro Diagnostics (IVD) Quality Control Market Regional And Country Analysis

  • 10.1. Global In Vitro Diagnostics (IVD) Quality Control Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global In Vitro Diagnostics (IVD) Quality Control Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market

  • 11.1. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China In Vitro Diagnostics (IVD) Quality Control Market

  • 12.1. China In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India In Vitro Diagnostics (IVD) Quality Control Market

  • 13.1. India In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan In Vitro Diagnostics (IVD) Quality Control Market

  • 14.1. Japan In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia In Vitro Diagnostics (IVD) Quality Control Market

  • 15.1. Australia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia In Vitro Diagnostics (IVD) Quality Control Market

  • 16.1. Indonesia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea In Vitro Diagnostics (IVD) Quality Control Market

  • 17.1. South Korea In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan In Vitro Diagnostics (IVD) Quality Control Market

  • 18.1. Taiwan In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia In Vitro Diagnostics (IVD) Quality Control Market

  • 19.1. South East Asia In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe In Vitro Diagnostics (IVD) Quality Control Market

  • 20.1. Western Europe In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK In Vitro Diagnostics (IVD) Quality Control Market

  • 21.1. UK In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany In Vitro Diagnostics (IVD) Quality Control Market

  • 22.1. Germany In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France In Vitro Diagnostics (IVD) Quality Control Market

  • 23.1. France In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy In Vitro Diagnostics (IVD) Quality Control Market

  • 24.1. Italy In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain In Vitro Diagnostics (IVD) Quality Control Market

  • 25.1. Spain In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market

  • 26.1. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia In Vitro Diagnostics (IVD) Quality Control Market

  • 27.1. Russia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America In Vitro Diagnostics (IVD) Quality Control Market

  • 28.1. North America In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA In Vitro Diagnostics (IVD) Quality Control Market

  • 29.1. USA In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada In Vitro Diagnostics (IVD) Quality Control Market

  • 30.1. Canada In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America In Vitro Diagnostics (IVD) Quality Control Market

  • 31.1. South America In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil In Vitro Diagnostics (IVD) Quality Control Market

  • 32.1. Brazil In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East In Vitro Diagnostics (IVD) Quality Control Market

  • 33.1. Middle East In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa In Vitro Diagnostics (IVD) Quality Control Market

  • 34.1. Africa In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. In Vitro Diagnostics (IVD) Quality Control Market Regulatory and Investment Landscape

36. In Vitro Diagnostics (IVD) Quality Control Market Competitive Landscape And Company Profiles

  • 36.1. In Vitro Diagnostics (IVD) Quality Control Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. In Vitro Diagnostics (IVD) Quality Control Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. In Vitro Diagnostics (IVD) Quality Control Market Company Profiles
    • 36.3.1. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. LGC Limited. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Roche Diagnostics AG Overview, Products and Services, Strategy and Financial Analysis

37. In Vitro Diagnostics (IVD) Quality Control Market Other Major And Innovative Companies

  • Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc.

38. Global In Vitro Diagnostics (IVD) Quality Control Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The In Vitro Diagnostics (IVD) Quality Control Market

40. In Vitro Diagnostics (IVD) Quality Control Market High Potential Countries, Segments and Strategies

  • 40.1 In Vitro Diagnostics (IVD) Quality Control Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 In Vitro Diagnostics (IVD) Quality Control Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 In Vitro Diagnostics (IVD) Quality Control Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer